Novel treatment of severe eosinophilic asthma
/
Saved in:
| Main Author: | article editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2020-02-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1797 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
by: Tomohito Takeshige, et al.
Published: (2024-12-01) -
The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma
by: Rimkunas A, et al.
Published: (2025-03-01) -
Determination of sputum eosinophil count and serum absolute eosinophil count in patients with bronchial asthma and its correlation with disease severity and response to treatment
by: Princia Banu Mangattu Parambil, et al.
Published: (2023-09-01) -
Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019-11-01) -
Efficacy of Benralizumab in Reducing FeNO in Severe Eosinophilic Asthma: The Role of CRSwNP
by: Garcia-Rivero JL, et al.
Published: (2025-05-01)